Heron Therapeutics stock awaits its next reported figures

Published on 09/22/2026 at 05:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Heron Therapeutics stock enters September 22, 2026, without a substantiated market quote in the available data. Its latest reported period remains the key reference point.

HRTX, US4277461020, Illustration mit AI erstellt.

Heron Therapeutics, Inc. (ISIN US4277461020) has no substantiated price figure available for September 22, 2026, so the article centers on the company's reported operating data and scheduled disclosures.

Reported figures set the baseline

Heron's most recent reported revenue, earnings, margin and guidance figures are not reproduced in the available dated results. Those measures remain essential for assessing whether the stock's valuation is supported by operating performance.

Dates matter for the next update

A future reporting date, analyst target or company catalyst is not substantiated by the available dated results. The next verified company disclosure therefore remains the relevant checkpoint for any updated revenue or earnings comparison.

Market data require a dated quote

Heron Therapeutics trades on Nasdaq under the ticker HRTX. The company's shares and market capitalization should be assessed using one consistent Nasdaq quotation and one matching as-of date.